Programs, the Department of Human Services, the Department of
Health, the Pennsylvania Board of Probation and Parole and
the Pennsylvania Commission on Crime and Delinquency.
(4) MAKE A FORM AVAILABLE TO PROVIDERS TO BE USED TO
CONFIRM THAT AN OFFENDER IS ELIGIBLE FOR AND ENROLLED IN THE
PROGRAM.
(4) (5) Promulgate any rules and regulations necessary
to implement this chapter.
§ 4606. Prior authorization.
Long acting injectable naltrexone shall not be subject to BE
APPROVED AS PART OF A prior authorization PROCESS by any
Medicaid managed care plan operating under contract with the
Commonwealth . FOR ELIGIBLE OFFENDERS ENROLLED IN THE PROGRAM AND
RECEIVING COMPREHENSIVE SUBSTANCE ABUSE TREATMENT WHICH INCLUDES
THE MONITORING OF MEDICATION ADHERENCE UPON THEIR RELEASE FROM
COUNTY CORRECTIONAL INSTITUTIONS. Within 90 days of the
effective date of this section, the Department of Human Services
shall issue a bulletin notice to prohibit INSTRUCT Medicaid
managed care plans from requiring prior authorization THAT
APPROVAL for the use of long acting injectable naltrexone . MUST
BE GRANTED IF THE ELIGIBLE OFFENDERS ARE ENROLLED IN THE PROGRAM
UPON THEIR RELEASE FROM COUNTY CORRECTIONAL INSTITUTIONS.
§ 4607. Report to General Assembly.
By June 30, 2016 WITHIN 18 MONTHS OF THE EFFECTIVE DATE OF
THIS SECTION , the department shall issue a report to the
Judiciary Committee of the Senate and the Appropriations
Committee of the Senate and the Judiciary Committee of the House
of Representatives and the Appropriations Committee of the House
of Representatives evaluating the effectiveness of the program.
The report shall include:
20150SB0524PN0786 - 4 -
<--
<--
<--
<--
<--
<--
<--
<--
<--
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30